| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/13/1994 | CN1089262A 4-substituted 1,2,4-triazole derivatives |
| 07/12/1994 | US5329010 Unsaturated groups with heteroarylalkyl groups and carboxy derivatives |
| 07/12/1994 | US5328991 Preparation of alkali-modified cat dander allergen (Fel d I) for immunotherapeutic purposes |
| 07/12/1994 | US5328986 Smooth muscle mitogen |
| 07/12/1994 | US5328955 Using a hydrophilic polyethylene |
| 07/12/1994 | US5328927 Tachykinin antagonists |
| 07/12/1994 | US5328924 Thiadiazole hydropyridines as cognition activators for Alzheimer*s disease |
| 07/12/1994 | US5328923 Compounds contain tetrahydropyridine ring and thiadiazole ring, Alzheimer*s disease, glaucoma, pain relief |
| 07/12/1994 | US5328922 Indole ureas as 5 ht receptor antagonist |
| 07/12/1994 | US5328912 Certain azacycloalkyl imidazopyrimidines; a new class of GABA brain receptor ligands |
| 07/12/1994 | US5328911 Biphenylmethane derivative and pharmacological use |
| 07/12/1994 | US5328909 Cyclopropenone derivatives |
| 07/12/1994 | US5328908 Antimicrobial quinolone thioureas |
| 07/12/1994 | US5328901 Respiratory system disorders |
| 07/12/1994 | US5328891 DNA codes and proteins |
| 07/12/1994 | US5328686 Treatment of acne or of pseudofolliculitis barbae |
| 07/12/1994 | CA1330633C Structured lipid containing dairy fat |
| 07/07/1994 | WO1994014958A1 Synthetic polynucleotides |
| 07/07/1994 | WO1994014838A1 Antibiotics ge 37468 a, b and c |
| 07/07/1994 | WO1994014832A1 Purine derivatives |
| 07/07/1994 | WO1994014814A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor |
| 07/07/1994 | WO1994014807A1 Substituted triols |
| 07/07/1994 | WO1994014806A1 Serotoninergic ergoline derivatives |
| 07/07/1994 | WO1994014800A1 Styril derivatives and processes for their preparation |
| 07/07/1994 | WO1994014793A1 Cyclic sulfone containing retroviral protease inhibitors |
| 07/07/1994 | WO1994014780A1 Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors |
| 07/07/1994 | WO1994014777A1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 07/07/1994 | WO1994014772A1 Enantiomers of carbazole derivatives as 5-ht1-like agonists |
| 07/07/1994 | WO1994014766A1 Novel vitamin d analogues |
| 07/07/1994 | WO1994014473A1 Therapeutic combination containing interferon |
| 07/07/1994 | WO1994014467A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/07/1994 | WO1994014459A1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens |
| 07/07/1994 | WO1994014455A1 Bisphosphonate/estrogen therapy for treating and preventing bone loss |
| 07/07/1994 | WO1994014449A1 Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen |
| 07/07/1994 | WO1994014448A1 Novel combination of benzoquinazoline antifolates and protecting agents |
| 07/07/1994 | WO1994014442A1 Substituted pyridyl compounds useful as leukotriene antagonists |
| 07/07/1994 | WO1994014436A1 Retroviral protease inhibiting compounds |
| 07/07/1994 | WO1994014435A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 07/07/1994 | WO1994014434A1 Endothelin receptor antagonists |
| 07/07/1994 | WO1994014433A1 COMBINATION OF A CHOLESTEROL BIOSYNTHESIS INHIBITOR AND A β-LACTAM CHOLESTEROL ABSORPTION INHIBITOR |
| 07/07/1994 | WO1994014432A1 Use of prodelphinidines for treating ostearthritis |
| 07/07/1994 | WO1994014428A1 Reduction of hair growth employing sulfhydryl reactive compounds |
| 07/07/1994 | WO1994014412A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails |
| 07/07/1994 | WO1994014411A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
| 07/07/1994 | WO1994014343A1 Psyllium drink mix compositions |
| 07/07/1994 | WO1994010207A3 Truncated insulin-like growth factor binding proteins having mitogenic activity |
| 07/07/1994 | WO1994005791A3 Dorsal tissue affecting factor and compositions |
| 07/07/1994 | CA2153069A1 Cyclic sulfone moiety-containing hydroxyethylamine retroviral protease inhibitors |
| 07/07/1994 | CA2152912A1 Cycloalkyl amine bis-aryl squalene synthase inhibitors |
| 07/07/1994 | CA2152389A1 Therapeutic combination containing interferon |
| 07/07/1994 | CA2152341A1 Purine derivatives |
| 07/07/1994 | CA2152163A1 Use of vitamin d glycosides for the treatment or prevention of osteoporosis |
| 07/07/1994 | CA2152056A1 Substituted triols |
| 07/07/1994 | CA2151616A1 Antibiotics ge 37468 a, b and c |
| 07/07/1994 | CA2151251A1 Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor |
| 07/07/1994 | CA2151240A1 Biophosphonate/estrogen therapy for treating and preventing bone loss |
| 07/07/1994 | CA2149317A1 Compositions and method for providing improved analgesic effect |
| 07/07/1994 | CA2129846A1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 07/07/1994 | CA2112778A1 Aminoalkylphenyl compounds |
| 07/06/1994 | EP0605174A1 Delayed, Sustained-release pharmaceutical preparation |
| 07/06/1994 | EP0604995A1 Hydroxyamines N-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena |
| 07/06/1994 | EP0604624A1 Multimeric forms of human rhinovirus receptor protein |
| 07/06/1994 | EP0604603A1 Cadherin materials and methods |
| 07/06/1994 | EP0604529A1 Pyridine compounds for treating leukotriene-related diseases |
| 07/06/1994 | EP0604494A1 5-ht 4? receptor antagonists |
| 07/06/1994 | EP0604409A1 Compositions and methods for detecting and modulating rna activity and gene expression |
| 07/06/1994 | EP0205475B1 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| 07/06/1994 | CN1088936A Peg-interferon conjugates |
| 07/06/1994 | CN1025331C Process for preparing biphenylmethane derivative and its medicinal salt |
| 07/05/1994 | US5326905 Benzylphosphonic acid tyrosine kinase inhibitors |
| 07/05/1994 | US5326902 Oxyalkyne compounds, pharmaceutical compositions containing them and processes for preparing such compounds and compositions |
| 07/05/1994 | US5326898 Substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/05/1994 | US5326771 Piperidylmethyl-substituted chroman derivatives |
| 07/05/1994 | US5326768 5-hydroxytryptamine antagonists |
| 07/05/1994 | US5326757 Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 07/05/1994 | US5326357 Reconstituted cartridge tissue |
| 07/05/1994 | CA1330613C Amino acid derivatives |
| 07/05/1994 | CA1330536C Medicament for the treatment of a cognitive disorder |
| 07/05/1994 | CA1330535C Medicament for treating depression |
| 07/05/1994 | CA1330534C Medicament for the treatment of addiction |
| 07/01/1994 | CA2112611A1 Hydroxyamines n-acyl derivatives having scavenger activity and useful in acute and chronic pathologies associated with peroxidation and inflammation phenomena |
| 07/01/1994 | CA2086565A1 Pharmaceutical composition for treating pigmentation |
| 06/30/1994 | CA2605872A1 Intermediates for retroviral protease inhibiting compounds |
| 06/29/1994 | EP0604259A1 3-(Quinolin-6-yl-methyl)-4H-imidazol-4-one derivatives as angiotensin II antagonists |
| 06/29/1994 | EP0604186A1 Inhibitors of HIV protease useful for the treatment of aids |
| 06/29/1994 | EP0604143A2 Rapamycin loaded formed blood elements to induce immunosuppression |
| 06/29/1994 | EP0603769A1 Alpha-Aminoketone derivatives |
| 06/29/1994 | EP0603699A1 Substituted pyridines as HMG-CoA reductase inhibitors |
| 06/29/1994 | EP0603650A1 3,5-Substituted amino benzoylguanidines, process for their preparation, their use as medicine or diagnostic agent, as well as a medicine containing them |
| 06/29/1994 | EP0603649A1 Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines as HMG-CoA reductase inhibitors |
| 06/29/1994 | EP0603301A1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 06/29/1994 | EP0603278A1 Indole derivatives as 5-alpha-reductase inhibitor |
| 06/29/1994 | EP0603220A1 Azabicyclic compounds as 5-ht 4? receptor antagonists |
| 06/29/1994 | EP0603194A1 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis |
| 06/29/1994 | EP0470183B1 Fibroblast growth factor conjugates |
| 06/29/1994 | EP0406272B1 Production of insulin-like growth factor binding protein |
| 06/29/1994 | CN1088583A Phospholipi derivatives containing higher elements of the Vth main group |
| 06/29/1994 | CN1088582A Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present |
| 06/29/1994 | CN1088581A Endothelin receptor antagonists |
| 06/29/1994 | CN1088439A Methods of therapeutic and anaesthetic treatment and preparations therefor |